Reflections on Rosh Hashanah, the Jewish New Year

September 27, 2020

This reflection on Rosh Hashanah was written by Dorey Glenn, MD, MPH, assistant professor in the division of nephrology, and Bill Primack, MD, who retired from the division of nephrology in 2015. (Rosh Hashanah began September 18, 2020, and ended September 20, 2020) Rosh Hashanah is one of the most important holidays in the Jewish … Continued

Berkowitz Research Team Awarded Nearly $3 Million To Study Medically Tailored Meal Delivery Program

September 27, 2020

Seth Berkowitz, MD, MPH, assistant professor in the division of general medicine, is principal investigator for a five-year “R01” grant to support a randomized clinical trial involving 200 individuals with Type 2 diabetes and food insecurity. In partnership with Community Servings and Massachusetts General Hospital, the $2.9 million grant from the National Institutes of Health … Continued

Lin’s COVID-19 Research Highlighted In Endeavors Magazine

September 26, 2020

Jessica Lin, MD, MSCR, assistant professor of medicine in the division of infectious diseases, is featured in a new Endeavors article recognizing UNC researchers who are helping to make UNC the most cited university in the nation for coronavirus research. Lin leads a study exploring how COVID-19 spreads within households after members are infected. “Of course … Continued

Boyce Leads Longitudinal COVID-19 Study in Chatham County

September 26, 2020

Ross Boyce, MD, MSc, assistant professor in the division of infectious diseases, is currently leading a longitudinal study in Chatham County to understand how and why SARS-CoV-2 is spreading through this population — data that are direly needed since most of the current data rely on “imperfect disease markers,” or information about the disease that’s easier … Continued

Herce Answers Common Questions About COVID-19 Clinical Trials in Spanish Language Video

September 26, 2020

Michael Herce, MD, MPH, MSc, assistant professor of medicine in the division of infectious diseases, participated in a Q&A video, in Spanish, in an effort to reach Latino communities and encourage participation in COVID-19 clinical trials. The Latino communities in North Carolina and across the U.S. have been disproportionally affected by the coronavirus, which makes … Continued

Callahan Explains How the OAAA Is Addressing the Impact of Osteoarthritis in Podcast

September 26, 2020

In a recent “Joint Action” rheumatology podcast, Leigh Callahan, PhD, the Mary Link Briggs Distinguished Professor of Medicine in the division of rheumatology, allergy and immunology, highlights changes that are needed in health care systems and polices to reduce the impact of osteoarthritis, a leading cause of disability. She also recognizes the work of the Osteoarthritis Action Alliance (OAAA).

Sheikh Talks To WRAL About Fall Allergies and COVID-19

September 24, 2020

Saira Sheikh, MD, assistant professor of medicine in the division of rheumatology, allergy and immunology, discussed the nuances of allergy symptoms and those commonly associated with COVID-19 in an interview with WRAL’s Go Ask Mom. While the symptoms are similar, like cough and occasionally shortness of breath in kids with asthma and allergies, most symptoms … Continued

Sickbert-Bennett Tells Parents How To Safely Visit Museums During Pandemic

September 24, 2020

Emily Sickbert-Bennett, PhD, MS, told WRAL’s Go Ask Mom that while museums may be open, that doesn’t mean everyone can go back to visiting them like they did in the past. “Whatever the activity — playing sports, going to the beach or visiting a museum — there is risk during the pandemic,” said Sickbert-Bennett, associate professor … Continued

Adimora Receives UNC’s Thomas Jefferson Award

September 20, 2020

The annual Thomas Jefferson Award recognizes a UNC faculty member who, through personal influence and performance of duty in teaching, writing and scholarship, has best exemplified the ideals and objectives of Thomas Jefferson. UNC faculty members nominate candidates for the honor, which carries a cash prize; a faculty committee chooses the recipient. Chancellor Kevin Guskiewicz, … Continued

Cohen Says He Is Encouraged By Eli Lilly COVID-19 Antibodies Study

September 19, 2020

An antibody drug study by Eli Lilly and Company has shown that the coronavirus antibody LY-CoV555, developed by Indianapolis-based Lilly and the Canadian company AbCellera, prevents mild to moderately ill coronavirus patients from being hospitalized. The antibody is reported to work by recognizing the virus once a person is infected and attaching to it, which … Continued